Vivimed Labs Limited share price
NSE: VIVIMEDLAB · ISIN INE526G01021
Key numbers
- Market cap
- ₹ 46.0 Cr
- Current price
- ₹ 5.55
- 52-week high / low
- ₹ 29 / 5
- Stock P/E
- -
- Book value
- ₹ -5.8
- Dividend yield
- 0.00%
- ROCE
- -65.2%
- ROE
- 143.6%
- Debt to equity
- -1.89
- Sales growth (3 yrs)
- -27.9%
- Profit growth (3 yrs)
- -
- 1-year return
- 12.1%
About Vivimed Labs Limited
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 26 | 21 | 21 | 16 | 12 |
| Operating profit | -2 | -0 | -1 | -11 | -140 |
| Net profit | -6 | -5 | -7 | -17 | -147 |
| EPS (₹) | -0.68 | -0.66 | -0.88 | -2.00 | -17.74 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.